Claims
- 1-5. (Cancelled).
- 6. A pharmaceutical composition for the treatment or prevention of obesity, comprising an ERα selective compound and a pharmaceutically acceptable carrier.
- 7. The pharmaceutical composition of claim 6, wherein said ERα selective compound is an ERα agonist.
- 8-14. (Cancelled).
- 15. A pharmaceutical composition for the reduction of serum lipoprotein levels, comprising an ERα selective compound and a pharmaceutically acceptable carrier.
- 16. The pharmaceutical composition of claim 15, wherein said ERα selective compound is an ERα agonist.
- 17-21. (Cancelled).
Priority Claims (5)
Number |
Date |
Country |
Kind |
0100302.9 |
Jan 2001 |
GB |
|
0100298.9 |
Jan 2001 |
GB |
|
0100299.7 |
Jan 2001 |
GB |
|
0100301.1 |
Jan 2001 |
GB |
|
0105525.0 |
Mar 2001 |
GB |
|
Parent Case Info
[0001] This application claims the benefit of U.S. Provisional Application 60/275,023; 60/274,996; 60/275,047; and 60/274,995, all filed Mar. 12, 2001.
Provisional Applications (4)
|
Number |
Date |
Country |
|
60275023 |
Mar 2001 |
US |
|
60274996 |
Mar 2001 |
US |
|
60275047 |
Mar 2001 |
US |
|
60274995 |
Mar 2001 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09994292 |
Nov 2001 |
US |
Child |
10752146 |
Jan 2004 |
US |